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Biotin uptakeThe sodium-dependent multivitamin transporter (SMVT) plays an important role in biotin uptake in the
intestine and other cell types. While signiﬁcant knowledge has been gained with regard to regulation and
cell biology of the SMVT system, there is little known about its structure-function relationships. Here we
examined the role of each of the ten conserved (among species) cysteine residues in the function of the
human SMVT (hSMVT) using site-directed mutagenesis. Our results showed a signiﬁcant impairment in
biotin uptake only in cells transfected with hSMVT mutated at Cys294, but not at the other conserved cysteine
residues; the impairment in biotin uptake caused by mutating Cys294 was not related to the polar status of
substituting amino acid. The inhibition in hSMVT function upon mutating Cys294 was mediated via a signiﬁcant
reduction in the Vmax, but not the apparent Km, of the biotin uptake process, suggesting a decrease in the
number (and/or activity) of hSMVT but not afﬁnity. Biotinylation assay conﬁrmed this suggestion by showing
a marked reduction in the level of expression of the mutated protein at the cell membrane, without affecting
total cellular level of induced hSMVT. These results show an important role for Cys294 in the function and cell
biology of hSMVT.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Biotin, a member of the B-family of water-soluble vitamins, func-
tions as a coenzyme in critical metabolic reactions that include fatty
acid biosynthesis and gluconeogenesis [1]. Deﬁciency of biotin in
humans leads to serious clinical abnormalities that include neurolog-
ical and dermatological disorders as well as growth retardation [2].
Mammals cannot synthesize biotin and obtain the vitamin from
exogenous sources via intestinal absorption. Two sources of biotin
are available to humans one being dietary and the other is bacterial,
i.e., biotin that is supplied by the normal micro-ﬂora of the large
intestine [3–7]. Absorption of both of these sources of biotin in the
small and large intestine, respectively, occurs via a carrier-mediated
process that involves SMVT (the name was given to this system
because it also transports the vitamin pantothenic acid and the
metabolically important substrate, lipoate [8]. The gene that encodes
the human SMVT (hSMVT), i.e., SLC5A6, contains 17 exons. Topologi-
cally, the hSMVT protein is predicted to have 12 trans-membrane
domains (TMD) with both the N- and C-termini that are orientedrans Affairs and the National
d Long Beach, CA 90822, USA.
rights reserved.toward the cell interior [9,10]. Studies from our laboratory utilizing
gene silencing approach (gene-speciﬁc Si-RNA) have shown that
hSMVT is the major biotin transporter in intestine [11]. We have
also observed that the hSMVT protein is exclusively expressed at
the apical membrane domain of the polarized enterocytes [12].
Other studies have shown that the activity of hSMVT is regulated by
intracellular and extracellular factors via transcriptional and/or
post-transcriptional mechanism [13–17].
Information concerning the structure-function relationships of the
SMVT system is currently limited. We have previously shown an im-
portant role for His115 and His254 residues [18]. In another recent
study from our laboratory we found hSMVT to be glycosylated at
position Asn138 and Asn489, and that mutating these residues affects
functionality of hSMVT [13]. Furthermore, a role for PMA in modulating
the regulatory effect of protein kinase C on hSMVT function was also
studied [13].
Using a chemical approach, our previous studies have suggested
involvement of cysteine residues in the function of SMVT [19,20].
Incubation of rabbit intestinal brush border membrane vesicles
(BBMV) [19] and human liver HepG2 cells [20] with sulfhydryl
group (\SH) modifying reagents showed signiﬁcant inhibition in
biotin uptake. The mammalian SMVT (i.e., that of human, bovine,
rabbit, rat, and mouse) has ten conserved cysteine residues; which
of these residues are the targets of inhibition by sulfhydryl group
modifying agents is not clear. In this study we used site directed
Table 1
Combination of primers used for PCR.
Forward (F) and Reverse (R) Primers (5′-3′)
hSMVT-RT F TGTCTACCTTCTCCATCATGGA;
R TAGAGCCCAATGGCAAGAGA
β-actin F AAATGGGTTCTAGACCGCGGAGA;
R CATGCTCGATGCGGTACTTCA
C68A F GACCGCAAAATGGGCGCCCTTCCGGTGGCACTG;
R CAGTGCCACCGGAAGGGCGCCCATTTTGCGGTC
C104A F TATTGGTTCCTGGGCGCCTGCTACTTTCTGGGG;
R CCCCAGAAAGTAGCAGGCGCCCAGGAACCAATA
C144A F AAAACTGTGGGAGTGGCTGGAACTGTGACCTTC;
R GAAGGTCACAGTTCCAGCCACTCGCACAGTTTT
C187A F GCCCTGGGCATTGTCGCTACCGTCTATACAGCT;
R AGCTGTATAGACGGTAGCGACAATGCCCAGGGC
C294A F GCTGCTGTGCTCTCCGCCTATGCAGTGTTCCCC;
R GGGGAACACTGCATAGGCGGAGAGCACAGCAGC
C309A F TCCCTCTGCGTGGGCGCCCTCATTGGCCTGGTC;
R GACCAGGCCAATGAGGGCGCCCACGCAGAGGGA
C358A F GGGCTCTTCATTGCCGCCCTCTTCAGCGGCTCT;
R AGAGCCGCTGAAGAGGGCGGCAATGAAGAGCCC
C410A F GGCTATGGGCTGCTTGCTCTAGGAATGGCCTAT;
R ATAGGCCATTCCTAGAGCAAGCAGCCCATAGCC
C443A F CTGCTGGGACTCTTCGCCCTTGGAATGTTCTTT;
R AAAGAACATTCCAAGGGCGAAGAGTCCCAGCAG
C450A F GGAATGTTCTTTCCAGCTGCTAACCCTCCTGGT;
R ACCAGGAGGGTTAGCAGCTGGAAAGAACATTCC
C294S F GCTGCTGTGCTCTCCTCTTATGCAGTGTTCCCC;
R GGGGAACACTGCATAAGAGGAGAGCACAGCAGC
C294M F GCTGCTGTGCTCTCCATGTATGCAGTGTTCCCC;
R GGGGAACACTGCATACATGGAGAGCACAGCAGC
C628A F GGGAGCAGCTCCACCGCCATCCTCCAGGAGACC;
R GGTCTCCTGGAGGATGGCGGTGGAGCTGCTCCC
C628S F GGGAGCAGCTCCACCTCCATCCTCCAGGAGACC;
R GGTCTCCTGGAGGATGGAGGTGGAGCTGCTCCC
C577A F CTCCTTCCGTTGTCCGCTCAGAAGCGGCTCCAC;
R GTGGAGCCGCTTCTGAGCGGACAACGGAAGGAG
C583A F CAGAAGCGGCTCCACGCCAGGAGCTACGGCCAG;
R CTGGCCGTAGCTCCTGGCGTGGAGCCGCTTCTG
“hSMVT-RT” and “β-actin” represents the primer sequences used for quantitative real-
time PCR for hSMVT and β-actin respectively. The bold faced nucleotides represent the
mutation in respective primers used for site-directed mutagenesis.
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esis by mutating conserved Cys residues and our results showed that
mutation of Cys294, but not the other conserved cysteine residues,
leads to a signiﬁcant inhibition in biotin uptake. This inhibition was
mediated via a signiﬁcant decrease in the Vmax of the biotin uptake
process with no change in the apparent Km, and was the result of
impairment in expression of the carrier protein at the cell surface.
We also extended this study by mutating nonconserved cysteine
residues oriented to the cell interior as potential disulphide bridge
forming partner with Cys294. Result showed that mutation at Cys628
to alanine or polar serine causes signiﬁcant inhibition in biotin uptake
suggesting potential disulﬁde bridge formation with Cys294.
2. Materials and methods
2.1. Material
Radio labeled [3H]-biotin (Speciﬁc activity>30 Ci/mmol, radio-
chemical purity>98%) was purchased from American Radiolabeled
Chemicals (ARC, St. Louis, MO). All chemicals used are either of
analytical or molecular biology grades and purchased from commercial
sources.
2.2. Cell culture
The human retinal pigmented epithelial cells (ARPE19) were used
for uptake studies. We used these cells because they are easy to trans-
fect and they show robust efﬁciency in expressing transfected hSMVT
[9,18]. The cells were obtained from ATCC (Manassas, VA) and were
maintained in DMEM medium (Sigma, St. Louise, MO) supplemented
with 10% fetal bovine serum and penicillin (100 units/ml) and strep-
tomycin (100 μg/ml) as described by us previously [18].
2.3. Generation of hSMVT mutants and transient transfection
Quick Change II kit (Stratagen; La Jolla, CA) was used to perform
site-directed mutagenesis in hSMVT, cloned into pcDNA 3.1 (−)
[18] and GFP-N3 [12] vectors, respectively following manufacturer's
protocol. Brieﬂy, the corresponding template was PCR-ampliﬁed
using speciﬁc mutant primers (Table 1). Following DpnI digestion,
constructs were subsequently transformed into competent XL-1 blue
cells. Correct clone carrying the corresponding mutation was identiﬁed
by sequencing of the isolated plasmid (Laragen, Los Angeles, CA).
Transfection was performed using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) as described before [18].
2.4. Real-time PCR analysis
At 48 h post-transfection total RNA was isolated using TRizol
reagent (Invitrogen) and treated with DNAse I (Invitrogen). cDNA
was prepared by using iScript cDNA synthesis kit (Bio-Rad) and the
expression level was monitored in real-time PCR (Bio-Rad) using
speciﬁc primers (Table 1). The expression level was normalized by
using β-actin as an internal control and quantiﬁed by 2−ΔΔCT method
[21].
2.5. Uptake studies
Forty eight hours after transfection, biotin uptake was measured
in Krebs–Ringer (KR) buffer (in mM; 133 NaCl, 4.93 KCl, 1.23 MgSO4,
0.85 CaCl2, 5 glucose, 5 glutamine, 10 HEPES, 10 MES, pH 7.4) as de-
scribed previously [18]. Endogenous biotin uptake was measured in
control cell simultaneously transfected with pcDNA 3.1 (−) vector.
Protein concentrations of the total cell lysate were measured by Dc
protein assay kit (Bio-Rad) following the manufacturer's protocol,
and uptake was expressed by fmol/mg protein/unit time.2.6. Cell surface biotinylation assay
Cell surface expression of hSMVT (tagged to GFP) was quantiﬁed
using a cell surface biotinylation kit (Pierce Biotechnology, Rockford,
IL) as described by the manufacturer. Brieﬂy, 48 h following transfec-
tion cells were treated with sulfo-NHS-SS-biotin and the biotinylated
proteins were isolated by incubating the lysate with streptavidine-
agarose beads. Isolated protein was subjected to Western blot analysis
and membrane expression of hSMVT (i.e., hSMVT-GFP) was quantiﬁed
using speciﬁc antibody. Total cellular hSMVT-GFP protein was used for
normalization as described previously [13].
2.7. Western blotting
Forty eight hours after transfection with wild-type or mutant
hSMVT-GFP construct cells were lysed in Ripa buffer (Sigma) supple-
mented with protease inhibitors cocktail (Roche). Equal amount of
protein was loaded in NuPAGE 4-12% Bis-Tris gradient minigels
(Invitrogen). Following electrophoresis, the gel was electro blotted
onto PVDF membrane (Bio-Rad) and blocked overnight with blocking
buffer (LI-COR Biosciences, Lincoln, NE). The blot was simultaneously
probed with anti-GFP monoclonal antibodies (Clontech, Mountain
View, CA) (raised in mouse) and anti-β-actin antibody (Santa Cruz Bio-
technology Inc., Santa Cruz, CA) (raised in rabbit) for 90 min. The blot
was washed and incubated simultaneously with anti-mouse IR dye,
800 and anti-rabbit IR, 680 dye (Li-Cor) in 1:20,000 dilutions for
1 h at room temperature. Followed by washing the ﬂuorescent
A
160
80
120
*
0
40
Bi
ot
in
 u
pt
ak
e
 (fm
ol/
mg
  p
rot
ein
/10
 m
in)
Bi
ot
in
 u
pt
ak
e
 (fm
ol/
mg
  p
rot
ein
/10
 m
in)
B
120
40
80 * * **
0
SMVT (WT)Mock C294A C294S C294M
Fig. 2. Effect of mutating the conserved cysteine residues of hSMVT on biotin uptake in
transiently transfected ARPE19 cells. (A) Each of the ten conserved cysteine residues was
mutated to alanine and mutants were transiently transfected (individually) into ARPE19
cells. Biotin uptakewasmeasured 48 h following transfection in KR buffer at pH 7.4. Control
(Mock) was transiently transfected with empty vector [pcDNA 3.1(−)]. (B) Effect of polar
status of the replacing residue. The Cys294 residue was substituted with non-polar alanine,
polar serine, andmethionine respectively. Uptake data shown in (A) and (B) aremean±SE
of at least three independent experiments. *pb0.01, **pb0.05.
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Biosciences) using odyssey application software (version 3.0).
2.8. Statistical analysis
Data shown are means±SE of at least three independent determi-
nations. Uptake was expressed as fmol per milligram protein per
10 min; statistical signiﬁcance was determined by the Student's
t-test. Diffusion component was determined from the slope of
the uptake line between the point of origin and uptake at high
biotin concentration (1 mM); carrier-mediated uptake was deter-
mined by subtracting diffusion component from total uptake.
Kinetic parameters of the uptake process, i.e., apparent Km and
Vmax, were determined by non-linear regression analysis using
Graph Pad Prism software (Version 5.03) by ﬁtting data into
Michaelis–Menten equation.
3. Results
3.1. Effect of mutating conserved cysteine residues of hSMVT on
uptake function
The hSMVT protein has ten cysteine residues that are conserved in
other mammals (bovine, rabbit, mouse, and rat). These residues are
located at positions 68, 104, 144, 186, 294, 309, 358, 410, 443 and
450 of the hSMVT polypeptide. According to topology prediction,
Cys68 and Cys144 of the hSMVT polypeptide are extracellular, those
at position 294 and 450 are cytoplasmic, and Cys104, Cys186, Cys 309,
Cys358, Cys410 and Cys443 are located in the hydrophobic TMDs of
the hSMVT polypeptide (Fig. 1). We mutated each of the conserved
cysteine residues of the SMVT polypeptide to alanine and examined
the effect of the individual mutation on the function of hSMVT in
biotin uptake in transiently expressing ARPE 19 cells. The results
showed that mutating Cys294 to lead to a signiﬁcant (pb0.01)
inhibition in biotin uptake, while mutating the other conserved
cysteine residues to have no effect on hSMVT transport function
(Fig. 2A). To determine whether the dramatic loss of hSMVT function
upon mutating Cys294 to the non- polar alanine is due to lose of theCys577NH2
Extracellular
Intracellular
COOH
Cys104
Cys144
Cys187
Cys294
Cys309
Cys358
Cys410 Cys443
Cys450
Cys628
Cys583
Cys306
Cys105
Cys48
Fig. 1. Predicted membrane topology of hSMVT and location of the conserved cysteine residues. The hSMVT polypeptide is predicted to have 12 TMD [9]; ﬁlled circles depict the
location of conserved cysteine residue whereas empty circles represent position of non- conserved cysteine residues.
Fig. 3. Kinetic parameters of biotin uptake by Cys294-hSMVTmutant. Cells were transfected
with Cys294mutant or wild-type hSMVT. Biotin uptakewasmeasured in KR buffer at pH 7.4.
Mock represents endogenous carrier-mediated uptake in ARPE19 cells.
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Cys294 to the polar residue serine or to sulfur containing methionine
on the function of hSMVT. Again, a signiﬁcant inhibition in biotin
uptake was observed suggesting that it is the cysteine residue itself,
and neither its polar status nor the presence of sulfur residue, is
important for the function of hSMVT (Fig. 2B).3.2. Effect of mutating Cys294 on kinetic parameters of biotin uptake
by hSMVT
To determine whether the effect of mutating Cys294 is mediated
via an effect on the number/activity of the hSMVT carriers and/or
on their afﬁnity, we examined the effect of this mutation on kinetic
parameters (Vmax and apparent Km) of the biotin uptake process
following transient expression of the mutated protein in ARPE19
cells. Data were compared to kinetic parameters of biotin uptake by
cells transiently expressing the wild-type hSMVT. The results
(Fig. 3) showed that mutating Cys294 leads to a signiﬁcant (pb0.01)
inhibition in the Vmax (608.6±27.83 and 213.3±14.54 fmol/mg
protein/10 min for wild-type and the mutated hSMVT, respectively),
but not the apparent Km (14.28±2.009, and 14. 69±3.08 μM,
respectively) of the carrier-mediated biotin uptake process The1
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Fig. 4. Effect of mutating Cys294 on level of expression of hSMVT. Equal amounts of Cys294 an
hSMVT mRNA (real-time PCR; data normalized to β-actin), and (B) total cellular hSMVT pro
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shows a representative gel.ﬁndings suggest that mutating Cys294 leads to a decrease in the
number (and/or activity), but not afﬁnity, of hSMVT. This suggestion
was further tested below.
3.3. Effect of mutating Cys294on level of expression of hSMVT
To determine whether mutating Cys294 affects the level of expression
of cellular hSMVT protein and mRNA, we transiently transfected ARPE19
cells with equal amounts of Cys294 mutant and wild-type hSMVT and
performed real-time PCR and Western blotting, respectively (see
Materials and methods). The results showed similar level of total
hSMVT mRNA and hSMVT-GFP protein expression in cells transfected
with the mutated and wild-type hSMVT (Fig. 4A and B).
3.4. Effect of mutating Cys294 on level of expression of hSMVT protein at
the cell surface
To determine whether mutating Cys294 affects expression of the
hSMVT protein at the cell membrane, we performed surface
biotinylation assay. Equal amounts of hSMVT (WT)-GFP and
hSMVT (C294A)-GFP constructs were transiently transfected into
ARPE19 cells, followed by determination of the relative level of
hSMVT-GFP expression at the cell membrane compared to total
cellular expression (see Materials and methods). The results showed
a signiﬁcant (pb0.01; 60%) reduction in membrane expression of the
mutated compared to the wild-type hSMVT (Fig. 5).
3.5. Does Cys294of hSMVT polypeptide form a disulphide bridge with
other cysteine?
Cys residues of a polypeptide are known to form disulphide
linkage with other cysteine residues. To determine if hSMVTCys294
forms a disulphide bridge with other cysteine residue of the protein
(the hSMVT has six non-conserved cysteine residues in addition to
the 10 conserved residues), we subjected the hSMVT to computational
analysis (CYS_REC from Softberry. Inc, NY). Result of the analysis
predicted a probable disulphide bond forming pattern between
Cys294 and Cys628 (similarly, Cys294 residue of SMVT of other mammals
was predicted to form similar bridge with non-conserved cysteinehS
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Fig. 5. Effect of mutating Cys294 on level of expression of hSMVT at cell surface. ARPE19
cells were transfected with Cys294 mutant and wild-type hSMVT. After 48 h of transfection,
biotinylation assay was performed (see Materials and methods). Induced expression of
hSMVT was identiﬁed using anti-GFP monoclonal antibody and level of membrane
expression was quantiﬁed by normalization relative to total amount of cellular
hSMVT. *pb0.01. Inset shows representative Western blot image.
101A. Ghosal, H.M. Said / Biochimica et Biophysica Acta 1818 (2012) 97–102according to the analysis). We mutated other two cysteine residues
(Cys577 and Cys583) in addition to Cys628 as they are also located on
the cytoplasmic side of the membrane. Mutating Cys628 of the hSMVT
to alanine or serine led to a signiﬁcant inhibition in biotin uptake
compared to wild-type hSMVT, whereas mutating Cys577 or Cys583
did not show any inhibition (Fig. 6).
4. Discussion
The aim of the present study was to enhance our understanding of
the structure–activity relationships of the hSMVT system, with special
emphasis of the role of conserved cysteine residues in the function of
this membrane carrier. Previous studies from our laboratory using
group speciﬁc modiﬁers have suggested a role for cysteine residue
(s) in the function of SMVT in biotin transport [19,20]. The hSMVT
system has ten conserved (with other mammals) cysteine residues,
and it is unclear which cysteine residue(s) is (are) involved in
mediating this inhibition, i.e., which residues is important for SMVT
function. This issue was addressed using the molecular approach of
site-directed mutagenesis. Of the ten conserved cysteine residues,160
120
* *
80
0
40
SMVT(WT) C294AMock C577A C583A C628A C628S
Bi
ot
in
 u
pt
ak
e
 (fm
ol/
mg
 pr
oti
en
/10
 m
in)
Fig. 6. Effect of mutating the non-conserved Cys residues for identifying disulﬁde
bridge forming partner of Cys294. Non-conserved Cys residues (Cys577, cys583 and Cys628)
facing the cytoplasm were mutated to alanine and equal amount of constructs (3 μg)
was transfected intoARPE19 cells. Biotin uptakewas determined at 48 h after transfection.
Data are mean±SE of at least three independent experiments. *pb0.01.only Cys294 appeared to be important for the function of hSMVT as
mutating this site led to a signiﬁcant inhibition in biotin uptake.
This inhibition occurred regardless of whether Cys294 was replaced
by a non polar amino acid (alanine) or by another polar residue
(serine), suggesting that it is the cysteine itself (and not its polar
status) that is important for hSMVT function. We also examined the
effect of mutating Cys294 to the sulfur containing amino acid methionine
and observed comparable inhibition in biotin uptake conﬁrming the
importance of Cys residue itself.
The inhibition in biotin uptake upon mutating Cys294 of the
hSMVT was mediated via a signiﬁcant decrease in the Vmax, but not
apparent Km, of the biotin uptake process. These ﬁndings suggest
that the inhibition is mediated via a decrease in the number (and/or
activity) but not afﬁnity of the SMVT system. We next examined
whether mutating Cys294 of hSMVT affects the steady state level of
expression of hSMVT. Quantitative PCR data and Western blot
analysis of total cell lysate showed similar level of mRNA and total
hSMVT protein expression, respectively in cells transfected with the
mutant and wild-type hSMVT; thus, we excluded the possibility of
an effect(s) of the Cys294 mutation on hSMVT level of expression.
However, since mutating a residue of a membrane protein could
affect its level of expression at the cell surface (without affecting its
total cellular level of expression) [18], we tested this possibility
employing biotinylation assay. Our results indeed showed that the
level of membrane expression of the mutated hSMVT is markedly
lower than that of the wild-type protein. This ﬁnding clearly indicates
that the inhibition in biotin uptake upon mutating Cys294 of hSMVT
protein is due to a decrease in the number of the hSMVT molecule
at the cell surface.
Cysteine residue in a given protein can form a disulphide bridge
with other cysteine residues. To determine if Cys294 forms such bridge
with other cysteine residues,we subjected the hSMVT to computational
analysis. The result predicted Cys628 as probable bonding partner of
Cys294. It is interesting to mention here that Cys628 and Cys294 of
hSMVT are oriented toward the cytoplasm. In addition, we examined
the role of nearby cysteine residues (Cys577 and Cys583), which are
also located in the cytoplasmic tails of hSMVT. Mutating Cys628 (but
not Cys577 or Cys583) led to a signiﬁcant inhibition in biotin uptake com-
pared to wild-type hSMVT, thus, lending support to possible existence
of a linkage between Cys294 and Cys628. Of note, whether Cys294 and
Cys628 also interact with accessory protein(s) (that is a component of
the transport machinery) apart from interacting with each other is not
known at this point and needs further research.
In summary, our study shows an important role for the conserved
Cys294 residue in the function of hSMVT in biotin uptake, and that this
role is mediated via affecting the expression of the hSMVT protein at
the cell surface.Acknowledgements
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